0 NASDAQ Companies - March 5, 2024Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s DiseaseData shows reduction of microglia activation and improvement in behavior in rodent models of Alzheimer’s disease (AD) and Parkinson’s disease […]Read More
0 NASDAQ Companies - March 5, 2024Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsALACHUA, Fla. and TAMPA, Fla., March 05, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]Read More
0 NASDAQ Companies - March 5, 2024Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program$10,000 scholarship to be awarded to a rising junior with a life science major attending a Pennsylvania-based four-year college or […]Read More
0 NASDAQ Companies - March 5, 2024Cipher Mining Provides Fourth Quarter and Full Year 2023 Business UpdateFourth Quarter GAAP Earnings of $10.6m and Non-GAAP Earnings of $27.8m Full Year 2023 Revenues of $126.8m Increased Hash Rate […]Read More
0 NASDAQ Companies - March 5, 2024First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth ConferenceBOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the […]Read More
0 NASDAQ Companies - March 5, 2024ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceRAMSEY, N.J. and BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the […]Read More
0 NASDAQ Companies - March 5, 2024Axsome Therapeutics to Present at the Leerink Partners Global Biopharma ConferenceNEW YORK, March 05, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel […]Read More
0 NASDAQ Companies - March 5, 2024Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK […]Read More
0 NASDAQ Companies - March 5, 2024Pharvaris to Participate in the Leerink Global Biopharma Conference 2024ZUG, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor […]Read More
0 NASDAQ Companies - March 5, 2024SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 ResultsBOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a […]Read More